NasdaqCM - Nasdaq Real Time Price USD

Envoy Medical, Inc. (COCH)

1.4000

0.0000

(0.00%)

At close: April 29 at 4:00:01 PM EDT

1.4700

+0.07

+(5.00%)

After hours: April 29 at 7:02:54 PM EDT

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear ImplantWhite Bear Lake, Minnesota--(Newsfile Corp. - March 31, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the fourth quarter and full year ended December

Newsfile 29 days ago

COCH
0.00%
COCHW
Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Seek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the reintroduction of the Hearing Device Coverage Clarification Act in both the U.S. House of Representatives and

Newsfile last month

COCH
0.00%
COCHW
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Billionaire Entrepreneur Glen Taylor, the Company's Largest Shareholder, Continues to Invest Significant Capital into the Company Furthering Its Progress White Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced securing $10 Million in financing from its largest existing shareholder, billionaire entrepreneur Glen Taylor. The financing pro

Newsfile last month

COCH
0.00%
COCHW
Envoy Medical to Participate in the 37th Annual ROTH Conference

White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced that it will participate in the 37th Annual ROTH Conference being held on March 16 - 18, 2025 at the Laguna Cliffs Marriott Resort and Spa in Dana Point, California.Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will be holding ...

Newsfile last month

COCH
0.00%
COCHW
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on providing hearing loss sufferers with innovative solutions today announces the successful enrollment of the first two participants in its pivotal clinical study. The purpose of the study is to investigate the safety and efficacy of the fully implanted Acclaim® cochlear implant and support its eventual premarket approval (PMA) application. I

Newsfile 2 months ago

COCH
0.00%
COCHW
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

White Bear Lake, Minnesota--(Newsfile Corp. - February 14, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on providing hearing loss sufferers with innovative solutions today announces additional patents for its growing patent portfolio. The US Patent & Trademark Office issued Envoy Medical Corporation US Pat. No. 12,214,195 on February 4, 2025. The title of the patent is Implantable Cochlear System with Inner Ear Sensor. This patent relates to ...

Newsfile 2 months ago

COCH
0.00%
COCHW
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Initial patient enrollment anticipated during first quarter of 2025 White Bear Lake, Minnesota--(Newsfile Corp. - December 19, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company, today announces it has selected seven study sites for participation in its pivotal clinical trial to investigate its fully implanted Acclaim® cochlear implant (Acclaim CI). Initial patient enrollment is anticipated to begin during the first quarter of 2025. The Investigational Device

Newsfile 4 months ago

COCH
0.00%
COCHW
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

WHITE BEAR LAKE, Minnesota , Dec. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on providing hearing loss suffers with innovative solutions today announces four new patents. The US Patent & Trademark Office issued Envoy Medical Corporation US Pat. No. 12,151,102 on November 25, 2024. The title of the patent is Combination Hearing Aid and Cochlear Implant System. This patent relates to updating a transfer function associated

GlobeNewswire 4 months ago

COCH
0.00%
COCHW
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT codes for the Company’s already FDA-approved fully implanted middle ear implant are two of the exciting developments for the growing companyWHITE BEAR LAKE, Minn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announces its corporate and financial results for the third qu

GlobeNewswire 5 months ago

COCH
0.00%
COCHW
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough fully implanted cochlear implant WHITE BEAR LAKE, Minnesota , Nov. 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces a peer-reviewed publication in Otology & Neurotology, discussing early experiences with and highlighting potential benefits of the Company’s investigational fully im

GlobeNewswire 5 months ago

COCH
0.00%
COCHW
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces that the European Patent Office has granted the Company Patent No. 3858425, titled,” Implantable Modular Cochlear Implant System with Communication System and Network.” The patent relates to a modular cochlear implant system configured to receive input signals from an implantable source and a wi

GlobeNewswire 5 months ago

COCH
0.00%
COCHW
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients WHITE BEAR LAKE, Minnesota, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces that its Investigational Device Exemption (IDE) application for its pivotal study of the Acclaim® Fully Implanted Cochlear Implant has been approved

GlobeNewswire 5 months ago

COCH
0.00%
COCHW
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

Twelve Members of the Independence Through Enhancement of Medicare and Medicaid (ITEM) Coalition Sign Letter to CMS Seeking Clarification of Prior Decision Making and Action to Bring Novel Hearing Technology to Medicare Beneficiaries WHITE BEAR LAKE, Minnesota, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, expresses gratitude to the Independence Through Enhancement of Medicare and Me

GlobeNewswire 6 months ago

COCH
0.00%
COCHW
Envoy Medical to Present at the LD Micro Main Event XVII

WHITE BEAR LAKE, Minnesota, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Main Event XVII. The conference is being held on October 28 – 30, 2024 at the Luxe Sunset Boulevard Hotel in Los Angeles. Event: LD Micro Main Event XVII Presentation Date: Tuesday, October 29, 2024 T

GlobeNewswire 6 months ago

COCH
0.00%
COCHW
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device

The Esteem® device is the only totally implantable active middle ear implant with FDA Approval, allowing the Company to be the first to capitalize on the new codes WHITE BEAR LAKE, Minnesota, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical, Inc. (NASDAQ: COCH), a market leader in fully implanted hearing devices, today announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel has approved five Category III CPT codes for totally implantable active m

GlobeNewswire 6 months ago

COCH
0.00%
COCHW
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

Performance of COCH after de-SPAC sixty day “washout” period among leaders in peer group and Envoy Medical bullish on its long-term strategy WHITE BEAR LAKE, Minnesota , Oct. 01, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today commemorates its one-year anniversary trading as a public company. On September 29, 2023, the formerly private Envoy Medical merged with Anzu Special Purpose Acquis

GlobeNewswire 6 months ago

COCH
0.00%
COCHW
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

During “The Claman Countdown,” the billionaire investor and entrepreneur noted how hearing aid modes in next-gen wireless earbuds can work with Envoy Medical’s fully implanted hearing devices WHITE BEAR LAKE, Minnesota, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: “COCH”), a hearing health company focused on fully implanted hearing systems, today highlights an interview with key investor Glen Taylor on Fox Business News “The Claman Countdown” in which he com

GlobeNewswire 7 months ago

COCH
0.00%
COCHW
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant Hearing Loss WHITE BEAR LAKE, Minnesota, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces it has been awarded another patent from the US Patent & Trademark Office for its fully implanted devices. On September 3rd, the Company was is

GlobeNewswire 7 months ago

COCH
0.00%
COCHW
Envoy Medical Secures Lending Facility of $10M

Glen Taylor, Committed Investor and Believer in Envoy Medical’s Mission to Help People with Significant Hearing Loss, Provides Significant Additional Funding as the Company Eyes Important Milestones and Seeks to Grow Hearing Implant Market with Breakthrough Device WHITE BEAR LAKE, Minnesota, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing devices, today announces entry into an add

GlobeNewswire 7 months ago

COCH
0.00%
COCHW
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully implanted Acclaim® cochlear implant; Maintains goal of starting Pivotal Clinical Trial by end of the year WHITE BEAR LAKE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announces its corporate and financial resu

GlobeNewswire 8 months ago

COCH
0.00%
COCHW

Performance Overview

Return	COCH	S&P 500 (^GSPC)
YTD	-2.10%	-5.45%
1-Year	-71.49%	+8.69%
3-Year	-85.71%	+34.58%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Envoy Medical, Inc. (COCH)

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Envoy Medical to Participate in the 37th Annual ROTH Conference

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

Envoy Medical to Present at the LD Micro Main Event XVII

American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device

Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Envoy Medical Secures Lending Facility of $10M

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Performance Overview